BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Smart Calendars AI//CalFeed//EN
CALSCALE:GREGORIAN
METHOD:REQUEST
X-WR-CALNAME:NIH — Effects of an Initial Anti-CD19 CAR T-cell Therapy on Su
 bsequent Anti-CD22 CAR T-cell Manufacturing and Clinical Outcomes in Patie
 nts with Relapsed/Refractory LBCL
BEGIN:VEVENT
UID:b34299f1-a005-40f3-b04e-435b4dd5fefd.nih:event:48963:2026-12-17:1400@sm
 artcalendars.ai
DTSTAMP:20260717T203012Z
DTSTART:20261217T190000Z
DTEND:20261217T200000Z
SEQUENCE:0
SUMMARY;LANGUAGE=en:NIH — Effects of an Initial Anti-CD19 CAR T-cell Therap
 
 y on Subsequent Anti-CD22 CAR T-cell Manufacturing and Clinical Outcome
 s i
 n Patients with Relapsed/Refractory LBCL
LOCATION;LANGUAGE=en:Online
DESCRIPTION;LANGUAGE=en:Seminar from the National Institutes of Health.\n\n
 
 Official event page: https://calendar.nih.gov/event/view/48963\n\nSourc
 e: 
 National Institutes of Health.
URL:https://calendar.nih.gov/event/view/48963
CATEGORIES:Conferences,Conference,Medical,Medical-Research,Nih,Seminar
END:VEVENT
END:VCALENDAR